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Summary 
 
The cell wall mycolyl-arabinogalactan-peptidoglycan complex is essential in mycobacterial 
species, such as Mycobacterium tuberculosis and is the target of several anti-tubercular drugs. 
For instance, ethambutol targets arabinogalactan biosynthesis through inhibition of the 
arabinofuranosyltransferases Mt-EmbA and Mt-EmbB. A bioinformatics approach identified 
putative integral membrane proteins, MSMEG2785 in Mycobacterium smegmatis, Rv2673 in 
Mycobacterium tuberculosis and NCgl1822 in Corynebacterium glutamicum, with 10 predicted 
transmembrane domains and a glycosyltransferase motif (DDX), features that are common to the 
GT-C superfamily of glycosyltransferases. Deletion of M. smegmatis MSMEG2785 resulted in 
altered growth and glycosyl linkag  analysis revealed the absence of AG (13)-linked 
arabinofuranosyl (Araf) residues. Complementation of the M. smegmatis deletion mutant was 
fully restored to a wild type phenotype by MSMEG2785 and Rv2673, and as a result, we have 
now termed this previously uncharacterized open reading frame, arabinofuranosyltransferase C 
(aftC). Enzyme assays using the sugar donor -D-arabinofuranosyl-1-monophosphoryl-
decaprenol (DPA) and a newly synthesized linear (15)-linked Ara5 neoglycolipid acceptor 
together with chemical identification of products formed, clearly identified AftC as a branching 
(13) arabinofuranosyltransferase. This newly discovered glycosyltransferase sheds further 
light on the complexities of Mycobacterium cell wall biosynthesis, such as in M. tuberculosis and 
related species and represents a potential new drug target. 
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Introduction 
Tuberculosis (TB) affects a third of the world population and causes 1.8 million fatalities 
annually (Dye, 2006). The spread of TB has been facilitated in recent years due to the 
susceptibility of HIV infected individuals to Mycobacterium tuberculosis, the etiological agent of 
TB (Paolo and Nosanchuk, 2004). The problem has also been compounded by the emergence of 
multi-drug resistant TB (MDR-TB) (Kaye and Frieden, 1996) and extensively drug-resistant 
(XDR)-TB strains (Shah et al., 2007). M. tuberculosis and other mycobacteria have a distinct cell 
wall which has a lipid-rich outer layer that is highly impermeable (Minnikin, 1982). One of the 
major components of this outer envelope are mycolic acids, long chain -alkyl, -hydroxy fatty 
acids that are essential for bacterial survival (Vilcheze et al., 2000; Portevin et al., 2004; Bhatt et 
al., 2005; Parish et al., 2007). These are found either esterified to the non-reducing termini of 
arabinogalactan (AG), or are present as trehalose esters, such as trehalose dimycolate (TDM) 
(Brennan and Nikaido, 1995; Dover et al., 2004). 
 
A common feature of members of the Corynebacterianeae is that they all possess this unusual 
cell wall architecture (McNeil et al., 1990, 1991; Besra et al., 1995). Apart from mycolic acids, 
the cell wall is dominated by a second macromolecule, an essential heteropolysaccharide termed 
arabinogalactan (AG), which is linked to both mycolic acids and peptidoglycan, forming the 
mycolyl-arabinogalactan-peptidoglycan (mAGP) complex (Daffé et al., 1990; McNeil et al.,
1990; McNeil et al., 1991; Besra et al., 1995). The formation of the arabinan domain (15,
13 and 12 glycosyl linkages) of AG results from the subsequent addition of 
arabinofuranose (Araf) residues by a set of unique arabinofuranosyltransferases including, the 
Emb proteins of which 3 paralogues exist in Mycobacterium avium (Belanger et al., 1996) and 
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M. tuberculosis (Telenti et al., 1997), AftA (Alderwick et al., 2006a) and AftB (Seidel et al.,
2007a). The lipid linked sugar donor -D-arabinofuranosyl-1-monophosphoryldecaprenol (DPA) 
(Wolucka et al., 1994; Lee et al., 1995; Lee et al., 1997), serves as the substrate molecule for 
these complex membrane bound glycosyltransferases.  
 
The anti-tuberculosis drug ethambutol (EMB) was shown to specifically inhibit AG biosynthesis 
(Takayama and Kilburn, 1989). The precise molecular target of EMB occupies the embCAB 
locus in M. tuberculosis (Telenti et al., 1997). To further define the role of EmbCAB proteins in 
cell wall arabinan biosynthesis, embA, embB and embC were individually inactivated in 
Mycobacterium smegmatis (Escuyer et al., 2001; Zhang et al., 2003). All three mutants were 
viable, however, the non-reducing terminal Ara6 motif which is the template for mycolylation in 
AG (McNeil et al., 1991) was altered in both the Ms-embA and Ms-embB mutants (Escuyer et 
al., 2001), whilst Ms-embC was shown to be involved in the formation of the arabinan domains 
of lipoarabinomannan (LAM) (Zhang et al., 2003). Attempts to obtain deletion mutants of embA 
(Amin et al., 2008) and embB in M. tuberculosis and embAB in M. smegmatis have proved 
unsuccessful (G.S. Besra, unpublished results). In contrast, deletion of the single Cg-emb 
orthologue and chemical analysis of the cell wall revealed a novel truncated AG structure 
possessing only terminal (t)-Araf residues with a corresponding loss of cell wall bound mycolic 
acids (Alderwick et al., 2005). The presence of a novel enzyme responsible for “priming” the 
galactan domain for further elaboration by Emb proteins led to the identification of AftA 
(Alderwick et al., 2006a). Recently, a retaining GT-C enzyme was identified, now termed AftB, 
which is responsible for the attachment of terminal (12) Araf residues, and marks the “end 
point” for AG arabinan biosynthesis (Figure 1) before decoration with mycolic acids (Seidel et 
al., 2007a).  
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It is clear that additional arabinofuranosyltransferases involved in AG and LAM biosynthesis 
still remain to be identified. Indeed, Liu and Musheginan (2003) identified fifteen members of 
the GT-C superfamily residing in M. tuberculosis, representing candidates involved in the 
biosynthesis of cell wall related glycans and lipoglycans (Liu and Mushegian, 2003). We have 
continued our earlier studies (Alderwick et al., 2006a; Alderwick et al., 2006b; Seidel et al.,
2007a) to identify genes required for the biosynthesis of the core structural elements of the 
mAGP complex by studying mutants of M. smegmatis and the orthologous genes and enzymes of 
M. tuberculosis and C. glutamicum. Herein, we present MSMEG2785, Rv2673c and NCgl1822 
as a new distinct arabinofuranosyltransferase of the GT-C superfamily, which is responsible for 
the transfer of Araf residues from DPA to the arabinan domain to form (13)-linked Araf
residues, which result in the branched arabinan domain distal to the non-reducing terminal Ara6
motif characteristic of mycobacterial AG.  
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Results 
 
Genome comparison of the Rv2673 locus 
 
The arabinofuranosyltransferases EmbA, EmbB, and EmbC are vital for M. tuberculosis and 
represent a target for the established drug EMB (Mikusova et al., 1995; Belanger et al., 1996;
Telenti et al., 1997). Structural considerations of these proteins and a search for new drug targets 
resolved that more than 16 related proteins are present in M. tuberculosis, possibly also acting as 
glycosyltransferases (Liu and Mushegian, 2003). In our systematic analysis of GT-C 
glycosyltransferases, focusing on those present in M. tuberculosis and C. glutamicum, we have 
previously identified the arabinofuranosyltransferases AftA (Alderwick et al., 2006a) and AftB 
(Seidel et al., 2007a), as well as several -mannosyltransferases (Mishra et al., 2007; Mishra et 
al., 2008). Each of these glycosyltransferases plays a specific yet decisive role in cell wall 
biosynthesis and assembly. In silico analysis of one of the putative glycosyltransferases of M. 
tuberculosis, Rv2673, highlighted that orthologues are present in a range of species belonging to 
the sub-order Corynebacterianeae, including the families Mycobacteriaceae, Corynebacteriacea 
and Nocardiaceae (Figure 2A). Furthermore, the organization of the gene locus is largely 
retained. The adjacent genes are largely of unknown function. RibD encodes a bifunctional 
deaminase-reductase domain, followed by a gene product containing a hydrolase domain, which 
is however absent in Corynebacterium, and downstream of Rv2673 a gene of unknown function 
is present. The wide distribution of Rv2673, its syntenic organization, and the fact that it is 
retained even in M. leprae, strongly indicates a fundamental function of its product. According to 
our experimental analysis (see below) we annotated this gene arabinofuranosyltransferase C 
(aftC). 
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AftC of M. tuberculosis is 433 amino acid residues long. It is a hydrophobic protein and is 
predicted to possess 10 transmembrane-spanning segments (Figure 2B). However, in contrast to 
AftA, AftB or EmbC, it is characterized by the absence of a periplasmic carboxyterminal 
extension. The amino acid sequence among the Corynebacterianeae is very well conserved, and 
there are 43% identical residues shared by the M. tuberculosis and C. glutamicum proteins. The 
degree of conservation is particularly high in the loop regions, for instance between helix 1 and 
2, 3 and 4, or 6 and 7 (Figure 2B). The fully conserved aspartyl (D) and glutamyl (E) residues, 
which we propose to be involved in catalysis or substrate binding, are located in the first 
extended loop region (Liu and Mushegian, 2003), as we have demonstrated for similarly located 
aspartyl (D) residues of Cg-Emb and AftB (Seidel et al., 2007a; Seidel et al., 2007b). 
Interestingly, the long transmembrane helix 8 is well conserved and it is within this region that 
there is a strong identity to a membrane protein of Vibrio parahaemolyticus (CpsG). 
Furthermore, this gene is located in a gene cluster involved in the biosynthesis of a capsular 
polysaccharide within this pathogen (Guvener and McCarter, 2003). 
 
Construction and growth of mutants 
 
In order to delete aftC and study for possible consequences we generated a null mutant of M. 
smegmatis mc2155 MSMEG2785 (ortholog of Rv2673) using specialized transduction (Figure 
3A). In contrast to our C. glutamicum studies (see below) growth of M. smegmatisMaftC in 
comparison to M. smegmatis was poor in liquid medium (Figure 3B) and sensitive to the addition 
of Tween-80 on agar plates (>0.005%). Complementation of M. smegmatisMaftC with either 
pMV261-Ms-aftC or pMV261-Mt-aftC restored the mutant to a wild type phenotype (Figure 
3B). On solid media M. smegmatisMaftC had a smooth and glossy appearance in comparison to 
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the typical crenulated colony morphology found for wild type M. smegmatis (Figure 3C) and 
failed to stain as ‘acid-fast’ positive (data not shown). In addition, susceptibility of M. 
smegmatisMaftC to EMB and the hydrophobic antibiotics rifampicin and chloramphenicol was 
enhanced (minimal inhibitory concentration of 2, 100 and 10 µg/ml for wild type M. smegmatis 
in comparison to 0.4, 4 and 5 µg/ml for M. smegmatisMaftC, respectively) indicating increased 
permeability and that M. smegmatisMaftC had an altered cell wall. To study the function of the 
corynebacterial AftC the non-replicative plasmid pK19mobsacBaftC was constructed. This was 
used to transform C. glutamicum to kanamycin resistance, indicating integration in its 
chromosome (Supplementary Figure S1A). Loss of vector was obtained by selection for sucrose-
resistance yielding clones with aftC deleted. A PCR analysis with primer pairs P5 and P6 
resulted in the expected fragment of 2160 bp for the wild type and of 1065 bp for the deletion 
mutant, which was termed C. glutamicumaftC. Colonies of this mutant were more erose 
compared to the usual glossy appearance of the wild type colony (data not shown). In contrast to 
M. smegmatisMaftC the growth of the C. glutamicumaftC mutant on the salt medium CGXII 
possessed only a slightly reduced growth rate of 0.32 h-1, whereas, that of the wild type C. 
glutamicum was 0.39-1h (Supplementary Figure S1B). 
mAGP analyses from M. smegmatis, M. smegmatis)aftC, M. smegmatis)aftC pMV261-Ms-
aftC, M. smegmatis)aftC pMV261-Mt-aftC, C. glutamicum and C. glutamicum)aftC 
To study the function of mycobacterial aftC deletion, defatted cells were analyzed qualitatively 
for AG esterified mycolic acids and cell wall associated lipids from an equivalent starting 
amount of biomass for each strain due to differences in growth rate (Figure 3B). As expected, M. 
smegmatis exhibited a typical profile of cell wall bound , ’ and epoxy-mycolic acid methyl 
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esters (MAMEs), whereas, these products were drastically reduced in M. smegmatisMaftC 
(Figure 4A). In addition, complementation of M. smegmatisMaftC with either pMV261-Ms-aftC 
or pMV261-Mt-aftC (Figure 4A), led to the restoration of normal ‘levels’ of cell wall bound 
mycolic acids. Analysis of cell wall associated lipids in several independent experiments 
highlighted an apparent increase in TDM for the aftC deletion mutant. This was confirmed 
quantitatively through [14C]acetate labeling of cultures and equal loading of radioactivity of 
extractable free lipids from M. smegmatis, M. smegmatisMaftC and the complemented M. 
smegmatisMaftC strain using plasmids pMV261-Ms-aftC and pMV261-Mt-aftC (Figure 4B). 
Typically, wild type M. smegmatis synthesized 5250 cpm, whereas M. smegmatisMaftC afforded 
14676 cpm of TDM after equivalent loading of radioactivity and quantitative analysis by 
phosphorimaging. Complementation of M. smegmatisMaftC with either pMV261-Ms-aftC or 
pMV261-Mt-aftC restored the phenotype of the deletion mutant back to that of wild type M. 
smegmatis (Figure 4B). These results demonstrated that Ms-aftC and Mt-aftC are involved in a 
key aspect of arabinan biosynthesis, whereby deletion substantially perturbs tethering of mycolic 
acids to AG, which results in an increase in TDM production. 
 
The cell wall core (mAGP) was prepared from M. smegmatis and M. smegmatisMaftC as 
described (Daffé et al., 1990; Besra et al., 1995; Alderwick et al., 2005) and the ratio of Ara to 
Gal in mAGP determined by gas chromatography (GC) analysis of alditol acetates ( Daffé et al.,
1990; Besra et al., 1995; Escuyer et al., 2001; Alderwick et al., 2005) (Figure 5). The glycosyl 
composition was calculated based on a single rhamnosyl (Rha) residue per AG chain (McNeil et 
al., 1990). The glycosyl compositional analysis revealed a relative molar ratio of Rha:Ara:Gal of 
1:71:31 and an Ara:Gal ratio of 2.3:1 which is in accord with previous data (Escuyer et al., 
2001). The M. smegmatisMaftC mutant yielded AG with a significant reduction in Ara content 
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10 
concomitant with a relative increase in the amount of Gal. The M. smegmatisMaftC yielded an 
AG with a Rha:Ara:Gal ratio of 1:22:56 and an Ara:Gal ratio of 0.4:1. Complementation of M. 
smegmatisMaftC with either pMV261-Ms-aftC or pMV261-Mt-aftC, restored the Rha:Ara:Gal 
ratio to that of wild type M. smegmatis. Gas chromatography mass spectrometry (GC/MS) 
analysis of per-O-methylated alditol acetate derivatives prepared from M. smegmatis and M. 
smegmatisMaftC indicated the complete absence of 3,5-Araf branching residues and a significant 
reduction in t-Araf, 2-Araf and 5-Araf-linkages (Figure 6). Complementation of M. 
smegmatis,aftC with either plasmid encoding Ms-aftC or Mt-aftC restored the glycosyl linkage 
profile to that of wild type M. smegmatis (Figure 6). These results demonstrate that 
MSMEG2785 and Rv2673, are functionally equivalent and are involved in the synthesis of 3,5-
Araf branching residues. Interestingly, LAM preparations from M. smegmatisMaftC were 
truncated in size on SDS-PAGE analysis to ‘full-size’ LAM from wild type M. smegmatis.
Further purification and detailed chemical analyses of LAM from the aftC mutant strain are 
currently being undertaken and will be reported separately (H.L. Birch, unpublished results). 
 
In contrast to the mycolic acid studies performed with the mycobacterial aftC deletion mutant, C. 
glutamicum,aftC cells were analyzed quantitatively for AG esterified corynemycolic acids due 
to similar growth rates between strains (Supplementary Figure S1B). Wild type C. glutamicum 
exhibited the known profile of corynomycolic acid methyl esters (CMAMEs, 35345 cpm) 
(Supplementary Figure S2), whereas, cell wall bound CMAMEs were significantly reduced in C. 
glutamicumMaftC (8023 cpm). The above data was reassuring as the qualitative (M. 
smegmatis,aftC) and quantitative (C. glutamicum,aftC) analyses were comparable in terms of a 
reduction in cell wall bound mycolic acids (Figure 4A and Supplementary Figure S2). 
Importantly, these results have also shown that Cg-aftC is involved in a key aspect of arabinan 
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11 
biosynthesis, whereby deletion perturbs tethering of corynomycolic acids to AG. The GC/MS 
profiles of per-O-methylated alditol acetate derivatives of C. glutamicum and C. 
glutamicumMaftC are shown in Supplementary Figure S3 with C. glutamicumMaftC also clearly 
devoid of 3,5-Araf branching residues. 
 
In vitro arabinofuranosyltransferase activity with extracts of M. smegmatis, M. 
smegmatis)aftC and complemented strains 
 
Initial attempts to develop an in vitro assay using either purified recombinant expressed AftC or 
E. coli membranes expressing aftC, have thus far proved unsuccessful, probably due to the 
hydrophobic nature of the protein. In an alternative approach, we assessed the capacity of 
membrane preparations from M. smegmatis, M. smegmatisMaftC and M. smegmatisMaftC 
complemented with pMV261-Mt-aftC to catalyze arabinofuranosyltransferase activity in the 
presence of exogenous synthetic acceptors (Lee et al., 1997; Seidel et al., 2007a). 
 
We first assessed whether M. smegmatisMaftC was deficient in (15) and (12)
arabinofuranosyltransferase activity using an -D-Araf-(15)--D-Araf-O-(CH2)7CH3 (Ara2)
synthetic acceptor (Lee et al., 1997) and DP[14C]A as a sugar donor based on an established 
assay format for determining (15) and (12) arabinofuranosyltransferase activities (Lee et 
al., 1998). TLC/autoradiographic analysis of the products which were only synthesized in the 
presence of Ara2, when assayed with M. smegmatis membranes resulted in the formation of two 
products (A and B) (Figure 7A and B). The enzymatic synthesis of products A and B are 
consistent with our previous studies using mycobacterial (Lee et al., 1997) and corynebacterial 
(Seidel et al., 2007a) membrane preparations resulting in trisaccharide products as a result of 
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12 
(15) and (12) Araf linkages to the Ara2 acceptor (Figure 7A). Addition of EMB in several 
experiments, even at high concentrations of up to 1 mg/ml to the reaction mixture, resulted in a 
decrease in only the in vitro synthesized -D-[14C]Araf-(15)--D-Araf-(15)--D-Araf-O-
(CH2)7CH3 product A (Figure 7A and B). Assays performed with membranes from M. 
smegmatisMaftC and the pMV261-Mt-aftC complemented strain using the Ara2 synthetic 
acceptor gave a similar profile to that of wild type M. smegmatis (Figure 7B). The data clearly 
show that the M. smegmatisMaftC strain possesses comparable levels of EMB-sensitive (15)
and EMB-resistant (12) arabinofuranosyltransferase activity. 
 
The lack of (13) arabinofuranosyltransferase activity in the previously reported Ara2 and -
D-Araf-(15)--D-Araf-(15)--D-Araf-O-(CH2)7CH3 (Ara3) acceptor based assays (Lee et 
al., 1997) required the development of an arabinofuranosyltransferase assay using the Ara-
extended synthetic acceptor -D-Araf-(15)--D-Araf-(15)--D-Araf-(15)--D-Araf-
(15)--D-Araf-O-(CH2)8NH2 (Ara5) (Supplementary Experimental and Supplementary Figure 
S4) and DP[14C]A as a sugar donor (Lee et al., 1998). TLC/autoradiographic analysis of the 
products which are only synthesized in the presence of Ara5, when assayed with M. smegmatis 
membranes resulted in the formation of a single product X (Figure 8A) through the transfer of a 
single [14C]Araf residue, with a retardation factor (Rf) consistent with a synthetic Ara6 acceptor 
(Appelmelk et al., 2008) standard (Figure 8B). In addition, the synthesis of product X in over-
expression studies was enhanced. Consistently from two independent membrane preparations 
and assays performed in triplicate from M. smegmatis pMV261-Mt-aftC produced product X 
(6453 cpm) in comparison to membranes from wild type M. smegmatis (4289 cpm) in the above 
assays demonstrating that AftC was functionally involved in the synthesis of product X. The 
inclusion of EMB in several experiments, even at high concentrations of up to 1 mg/ml to the 
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reaction mixture did not inhibit the synthesis of this in vitro synthesized [14C]Araf-Ara5 (Figure 
8A, Product X) illustrating that the Ara5 acceptor was not extended via an EMB-sensitive 
(15) arabinofuranosyltransferase. Interestingly, membranes prepared from the M. 
smegmatisMaftC strain were unable to synthesize the in vitro product to the same level of activity 
that was observed with wild type membranes prepared from M. smegmatis (Figure 8A). This was 
to be expected, since our earlier in vivo and in vitro studies would have anticipated residual Ara6
product formation, considering that M. smegmatisMaftC possesses (12)
arabinofuranosyltransferase activity. Assays performed with membranes from the M. 
smegmatisMaftC pMV261-Mt-aftC complemented strain, gave a similar profile to that of wild 
type M. smegmatis (Figure 8A).  
 
To establish that the Ara5 acceptor is being utilized by two different 
arabinofuranosyltransferases, presumably establishing (12) and (13) linkages, assays 
similar to that used before were scaled up (see Experimental Procedures) and product X 
extracted and purified through preparative TLC for each membrane preparation. GC (Sassaki et 
al., 2005) and GC/MS (Alderwick et al., 2005) analyses of the partially per-O-methylated, per-
O-acetylated alditol acetate derivatives of product X in assays performed with M. smegmatis 
membranes revealed the addition of (12) [Rt 11.75 min; m/z 129, 130,161,190] and (13)
[Rt 12.39 min; m/z 118, 129, 130, 190, 202, 233] linked Araf residues (Figure 9A and B). 
Therefore, the product migrating below Ara5 and co-incident with the Ara6 acceptor standard on 
TLC (Figure 8A and B) is in fact a mixture of two products (Figure 9B). The addition of 
(12)-linked Araf residues can be attributed to the function of AftB. The presence of (13)-
linked Araf residues in this assay using an Ara5 acceptor clearly highlights the role of a novel 
arabinofuranosyltransferase(s) capable of functioning in an (13) capacity. Importantly, the 
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level of (13) activity when the Ara5 acceptor is incubated with membranes prepared from M. 
smegmatisaftC is completely abolished (Figure 9A). However, (12) activity is clearly 
present in M. smegmatisaftC (Figure 9A). In addition, M. smegmatisaftC complemented with 
pMV261-Mt-aftC restores (13) arabinofuranosyltransferase activity to wild type M. 
smegmatis (Figure 9A). The results clearly establish both from in vivo and in vitro experiments 
that AftC catalyzes the addition of an (13)-Araf unit via an (13)
arabinofuranosyltransferase and that this enzyme is also resistant to EMB (Figure 8A). 
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Discussion 
The mAGP complex represents one of the most important cell wall components of the 
Corynebacterianeae and is essential for the viability of M. tuberculosis (Vilcheze et al., 2000;
Pan et al., 2001; Gande et al., 2004; Mills et al., 2004). It is therefore not surprising that one of 
the most effective anti-mycobacterial drugs, EMB, targets its synthesis through inhibition of AG 
biosynthesis. However, the emergence of MDR-TB and XDR-TB has accelerated the need to 
discover new drug targets (Brennan and Nikaido, 1995). One of the strategies is to identify genes 
involved in AG biosynthesis. Based on this strategy we previously identified the presence of a 
new “priming” enzyme, now termed AftA, which would link the initial Araf unit with the C-5 
OH of a (16) linked Galf of a pr -synthesized galactan core (Alderwick et al., 2005), and  
more recently identified the AftB enzyme responsible for (12) Araf residues. 
 
The previously described Emb (Alderwick et al., 2005), AftA (Alderwick et al., 2006a) and AftB 
proteins (Seidel et al., 2007a) are distinct arabinofuranosyltransferases. Thus, despite some 
functional relationship, these glycosyltransferases have inherent specific features as evident from 
the insensitivity of AftA and AftB towards EMB, whereas the single Cg-Emb (Alderwick et al.,
2005; Radmacher et al., 2005), and Mt-Emb proteins are sensitive towards EMB (Telenti et al.,
1997; Belanger et al., 1996). The number of arabinofuranosyltransferases that are required for 
mycobacterial arabinan biosynthesis has been a matter of speculation to date depending on how 
the arabinan chains are assembled. The primary structure of AG (Besra et al., 1995; Daffé et al.,
1990) would suggest at least five distinct arabinofuranosyltransferases are required for the 
complete formation of AG. Interestingly, M. smegmatis embA and embB mutants were found to 
possess reduced amounts of the non-reducing terminal disaccharide -D-Araf-(12)--D-Araf
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and result in the removal of the dominant terminal non-reducing Ara6 branched motif in the 
mutant being replaced by a linear Ara4 motif (Escuyer et al., 2001). The authors of this study 
concluded that the M. smegmatis embA and embB mutants result in a lack of 3-arm branching off 
the main (15)-arabinan chain proximal to the non-reducing and attachment site of mycolic 
acids in AG (Escuyer et al., 2001). Initially, it was proposed that the -D-Araf-(12)--D-Araf
disaccharide was assembled using EmbA and EmbB. However, the recent identification of AftB, 
the development of specific in vitro assays in combination with mutant strains, and recent 
structural studies have fuelled speculation that EmbA/B act as (15)
arabinofuranosyltransferases (Bhamidi et al., 2008; Seidel et al., 2007a; Alderwick et al., 2005). 
 
In this study, we have identified MSMEG2785 (also Rv2673 and NCgl1822), which we have 
termed AftC, as a novel branching arabinofuranosyltransferase. More precisely, AftC catalyzes 
the addition of (13) Araf residues as shown through both in vivo and in vitro experiments, 
ultimately resulting in 3,5-Araf residues after further (15) extension, characteristic of AG. 
For instance, incubation of membranes prepared from M. smegmatis with DP[14C]A and a linear 
(15)-Ara5 neoglycolipid acceptor resulted in the synthesis of an Ara6 product. Further 
chemical characterization of the product by glycosyl linkage analysis established that the 
(15)-Ara5 acceptor was extended via an EMB resistant (13) arabinosfuranosyltransferase 
giving rise to 3-linked Araf residues and corroborated our earlier cell wall analysis of the M. 
smegmatisMaftC mutant. Since, it is now established that only (15)
arabinofuranosyltransferase(s) are EMB-sensitive it can be further speculated that EmbA and 
EmbB function in the assembly of the linear (15) arabinan segments as presented in Figure 
10, which is in accordance with previous data and the phenotype of a Cg-Emb mutant 
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(Alderwick et al., 2005). It is clear that further studies are required to establish the precise role of 
EmbA and EmbB in mycobacteria. 
 
The analysis of the M. smegmatisMaftC mutant to date and based on the Ara:Gal ratio would 
suggest that the residual arabinan segment in the mutant consists of approximately five Araf
residues: -D-Araf-(12)--D-Araf-(15)--D-Araf-(15)--D-Araf-(15)--D-Araf
located at three branches on the galactan chain (Alderwick et al., 2005; Besra et al., 1995). This 
is consistent with the recent primary structure of AG (Bhamidi et al., 2008), with a ‘non-
variable’ terminal non-reducing Ara17 motif, introduction of a 3,5-Araf residue distal to this non-
reducing end by AftC and further extension by a linear (15)Araf domain (Figure 10). The 
latter appears to be variable (up to 12/13 residues). However, based on M. smegmatisMaftC and 
the subsequent Ara:Gal compositional analysis a dominant Ara22/Ara23 motif would be consistent 
with recent (Bhamidi et al., 2008) and previous (Besra et al., 1995) structural data on AG and 
this is represented in terms of biosynthetic considerations in Figure 10. It is also possible that 
AftC or a second distinct (13) arabinosfuranosyltransferase (shown as AftD in Figure 10) 
may be involved in late stages of AG synthesis i.e. the non-reducing Ara6 motif and is consistent 
with our data and the model presented in Figure 10. 
 
The discovery of AftC has now shed new light on the key arabinofuranosyltransferases to build 
an arabinan domain typical for Corynebacterianae. In this context, the genomic organization in 
the genomes of the Corynebacterianae sequenced is intriguing, revealing high synteny of the M. 
tuberculosis aftC locus to the maps of all other Mycobacterium and Corynebacterium species. 
The identification of new cell wall biosynthetic drug targets is of great importance, especially 
with the emergence of MDR-TB. This newly discovered DPA dependent arabinofuranosyl 
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transferase represents, along with a straightforward in vitro enzyme assay, a promising candidate 
for further exploitation as a potential drug target. 
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Experimental procedures 
 
Bacterial strains and growth conditions. C. glutamicum ATCC 13032 (referred to the 
remainder of the text as C. glutamicum) and Escherichia coli DH5mcr were grown in Luria-
Bertani broth (LB, Difco) at 30°C and 37°C, respectively. The recombinant strains generated in 
this study were grown on complex Brain Heart Infusion medium (BHI, Difco), and the salt 
medium CGXII used for C. glutamicum as described (Eggeling and Bott, 2005). Kanamycin and 
ampicillin were used at a concentration of 50 µg/ml. M. smegmatis strains were grown in Tryptic 
Soy Broth (TSB; Difco) containing 0.005 % Tween80 (TSBT).  Solid media were made by 
adding 1.5 % agar to the above-mentioned broths. The concentrations of antibiotics used for M. 
smegmatis were 100 µg/ml for hygromycin and 20 µg/ml for kanamycin. Minimal inhibitory 
concentrations were determined by plating cells on solid media supplemented with various 
concentrations of EMB, rifampicin and chloramphenicol. The minimal inhibitory concentration 
was defined as the first concentration of drug that would inhibit 100% of growth after 5 days of 
incubation (Belanger et al., 1996). M. tuberculosis H37Rv DNA was obtained from the NIH 
Tuberculosis Research Materials and Vaccine Testing Contract at Colorado State University. All 
other chemicals were of reagent grade and obtained from Sigma-Aldrich.  
 
Construction of plasmids and strains. Approximately 1 kb of upstream and downstream 
flanking sequences of MSMEG2785 were PCR amplified from M. smegmatis mc2155 genomic 
DNA using the primer pairs MS2785LL 
(TTTTTTTTCCATAAATTGGATCCGCTGACCGACCTCATC) and MS2785LR 
(TTTTTTTTCCATTTCTTGGCGAGCCCGAGCTTGAAGTTG), and MS2785RL 
(TTTTTTTTCCATAGATTGGTTCCTGCTGCTGTCCCTTGG) and MS2785RR 
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(TTTTTTTTCCATCTTTTGGCGAACTCAGCGGCGATTCAC), respectively (all primers are 
given in 5’ to 3’ direction). Following restriction digestion of the primer incorporated Van91I 
sites, the PCR fragments were cloned into Van91I-digested p0004S to yield the knockout 
plasmid pMSMEG2785 which was then packaged into the temperature sensitive 
mycobacteriophage phAE159 as described previously (Bardarov et al., 2002) to yield phasmid 
DNA of the knockout phage phMSMEG2785. Generation of high titre phage particles and 
specialized transduction were performed as described earlier (Bardarov et al., 2002; Stover et al.,
1991). Deletion of MSMEG2785 in one hygromycin resistant transductant was confirmed by 
Southern blot. To enable expression of MSMEG2785 and Rv2673, in the deletion mutant, these 
were amplified using primer pairs designed for subsequent cloning into the mycobacterial-shuttle 
vector pMV261 (Stover et al., 1991). All cloned fragments were verified by sequencing. 
To construct the deletion vector pK19mobsacBMaftC (NCgl1822), crossover PCR was applied 
with primer pairs AB (A, CGTTAAGCTTCGATCTTGTTGATGTGTGGCATCACACG; B, 
CCCATCCACTAAACTTAAACAGCGCCATCAACAACATGG) and CD (C, 
TGTTTAAGTTTAGTGGATGGGTGATCCAACGCACGACCATC; D, 
GCATGGATCCACGCATACCGAGGGAAAGATCTTC) and C. glutamicum genomic DNA as 
template. Both amplified products were used in a second PCR with primer pairs AD to generate a 
656 bp fragment consisting of sequences adjacent to Cg-aftC, which was ligated with BamHI-
HindIII-cleaved pK19mobsacB. All plasmids were confirmed by sequencing. The chromosomal 
deletion of Cg-aftC was performed as described previously using two rounds of positive selection 
(Schafer et al., 1994), and its successful deletion was verified by use of two different primer 
pairs. 
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Isolation of the mAGP complex, glycosyl composition and linkage analysis of alditol 
acetates by GC and GC/MS. The thawed cells were resuspended in phosphate buffered saline 
containing 2% Triton X-100 (pH 7.2), disrupted by sonicaton and centrifuged at 27000 x g
(Besra et al., 1995; Alderwick et al., 2005). The pelleted material was extracted three times with 
2% SDS in phosphate buffered saline at 95°C for 1 h, washed with water, 80% (v/v) acetone in 
water, and acetone, and finally lyophilized to yield a highly purified cell wall preparation (Besra 
et al., 1995; Alderwick et al., 2005). Cell wall or per-O-methylated cell wall preparations 
(Alderwick et al., 2005) were hydrolyzed in 2 M TFA, reduced with NaB2H4 and the resultant 
alditols per-O-acetylated and examined by GC and GC/MS as described previously (Besra et al.,
1995; Alderwick et al., 2005). 
 
Extraction and analysis of cell wall bound mycolic acids. In terms of M. smegmatis strains 
equivalent amounts of freeze-dried bacilli (100 mg) were processed as described previously 
(Seidel et al., 2007a) following two consecutive CHCl3/CH3OH/H2O (10:10:3, v/v/v) extractions 
for 4 h at 50°C in the analysis of cell wall associated lipids, and cell wall bound MAMEs. 
Alternatively, M. smegmatis and C. glutamicum cultures (5 ml) were grown and metabolically 
labelled at mid-logarithmic phase of growth using 1 µCi/ml [1,2-14C]acetate (50-62 mCi/mmol, 
GE Healthcare, Amersham Bioscience) for 4 h at either 30°C or 37oC with gentle shaking, 
harvested, washed and freeze-dried. Cells were then extracted by two consecutive extractions 
with 2 ml of CHCl3/CH3OH/H2O (10:10:3, v/v/v) for 4 h at 50°C to provide cell wall associated 
lipids and analyzed as described previously (Seidel et al., 2007a). The crude lipid extracts were 
resuspended in CHCl3:CH3OH (2:1) and equivalent aliquots (50,000 cpm) analyzed by TLC 
using silica gel plates (5735 silica gel 60F254, Merck) developed in CHCl3:CH3OH:NH4OH 
(80:20:2, v/v/v) to separate [14C]-labeled TDM and phospholipids (Mikusova et al., 1995). 
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Lipids were visualized by autoradiography by overnight exposure of Kodak X-Omat AR film to 
the TLC plates to reveal labelled lipids, quantified by phosphorimaging and compared to know 
standards (Mikusova et al., 1995). The bound MAMEs/CMAMEs from the above de-lipidated 
extracts were released by the addition of 2 ml of 5% aqueous solution of tetra-butyl ammonium 
hydroxide followed by overnight incubation at 100°C. After cooling, water (2 ml), CH2Cl2 (4 ml) 
and CH3I (500 Ul) were added and mixed thoroughly for 30 min. The lower organic phase was 
recovered following centrifugation and washed three times with water (4 ml), dried and 
resuspended in diethyl ether (4 ml). After centrifugation the clear supernatant was again dried 
and resuspended in CH2Cl2 (100 µl). An aliquot (5 µl) from each strain was subjected to 
scintillation counting and an equivalent (5 µl) aliquot analyzed by TLC using silica gel plates 
(5735 silica gel 60F254, Merck), developed in petroleum ether/acetone (95:5, v/v) and either 
visualized by autoradiography by exposure of Kodak X-Omat AR film to the TLC plates to 
reveal [14C]-labeled MAMEs/CMAMEs, or charred following spraying with 5% 
molybdophosphoric acid in ethanol at 100oC and compared to know standards. 
 
Arabinofuranosyltransferase activity with membrane preparations of M. smegmatis, M. 
smegmatis pMV261-Mt-aftC, M. smegmatisaftC and M. smegmatisaftC pMV261-Mt-aftC.
Membranes were prepared as described previously (Lee et al., 1997Alderwick et al., 2006a) and 
resuspended in 50 mM MOPS (pH 7.9), containing 5 mM -mercaptoethanol and 10 mM MgCl2
(buffer A) to a final concentration of 15-10 mg/ml. The neoglycolipid acceptors used in this 
study were -D-Araf-(15)--D-Araf-(15)--D-Araf-(15)--D-Araf-(15)--D-Araf-O-
(CH2)8NH2 (Ara5, see Supplementary Material) and -D-Araf-(15)--D-Araf-O-(CH2)7CH3
(Ara2) (Lee et al., 1995; Lee et al., 1998). The acceptors (either Ara2 or Ara5) and DP[14C]A (Lee 
et al., 1995; Lee et al., 1998) (stored in CHCl3/CH3OH, 2:1, v/v) were aliquoted into 1.5 ml 
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eppendorf tubes to a final concentration of 2 mM and  200,000 cpm (90 µM), respectively, and 
dried under nitrogen. The arabinofuranosyltransferase assay was carried out as described 
previously (Lee et al., 1997) with modifications. IgePalTM (Sigma-Aldrich) was added (0.1%, 
v/v) with the appropriate amount of buffer A (final volume 80 µl). Tubes were sonicated for 15 
min to resuspend lipid linked substrates and then mixed with the remaining assay components, 
which included membrane protein from either M. smegmatis, M. smegmatis pMV261-Mt-aftC 
M. smegmatisMaftC or M. smegmatis,aftC pMV261-Mt-aftC (1 mg), 1 mM ATP, 1 mM NADP 
and in some cases EMB (0-1 mg/ml). Assays were incubated for 1 h at 37°C and quenched by 
the addition of 533 µl CHCl3/CH3OH (1:1, v/v). After mixing and centrifugation at 27000 x g for 
15 min at 4°C, the supernatant was removed and dried under nitrogen. The residue was then 
resuspended in 700 µl of CH3CH2OH/H2O (1:1, v/v) and loaded onto a 1 ml SepPak strong anion 
exchange cartridge (Supelco), pre-equilibrated with CH3CH2OH/H2O (1:1, v/v). The column was 
washed with 2 ml CH3CH2OH and the eluate collected, dried and partitioned between the two 
phases arising from a mixture of n-butanol (3 ml) and water (3 ml). The resulting organic phase 
was recovered following centrifugation at 3,500 x g and the aqueous phase again extracted twice 
with 3 ml of water-saturated n-butanol. The pooled extracts were back-washed twice with n-
butanol-saturated water (3 ml). The n-butanol fraction was dried and resuspended in 200 µl
butanol. The extracted radiolabeled material was quantified by liquid scintillation counting using 
10 % of the labeled material and 5 ml of EcoScintA (National Diagnostics, Atlanta). The 
incorporation of [14C]Araf was determined by subtracting counts present in control assays 
(incubations in the absence of acceptor). The remaining labeled material was subjected to thin-
layer chromatography (TLC) using either isopropanol:acetic acid:water (8:1:1, v/v/v) for the 
assays utilizing the Ara5 acceptor or CHCl3:CH2OH:H2O:NH4OH (65:25:3.6:0.5, v/v/v/v) in the 
case of the Ara2 acceptor on aluminum-backed Silica Gel 60 F254 plates (Merck, Darmstadt, 
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Germany). Autoradiograms were obtained by exposing TLCs to X-ray film (Kodak X-Omat) for 
3 days. 
 
Characterization of (13)-arabinofuranosyltransferase activity with membranes 
prepared from M. smegmatis, M. smegmatisaftC and M. smegmatisaftC pMV261-Mt-
aftC. Large-scale reaction mixtures containing cold DPA (200 µg, 0.75 mM) (Lee et al., 1997)
and 50 mM of the acceptor Ara5 were mixed and given an initial incubation at 37°C with 
membranes prepared from either M. smegmatis, M. smegmatisMaftC or M. smegmatis,aftC 
pMV261-Mt-aftC for 1 h. The assays were replenished with fresh membranes (1 mg) and re-
incubated for 1 h at 37 °C with the entire process repeated thrice. Products were extracted from 
reaction mixtures by n-butanol/water phase separation as described earlier to extract products. 
Products were applied to preparative TLC plates, developed in isopropanol:acetic acid:water 
(8:1:1, v/v/v) and sprayed with 0.01% 1,6-diphenylhexatriene in petroleum-ether:acetone (9:1, 
v/v), and the products localized under long-wave (366 nm) UV light (Lee et al., 1997). The plate 
was then re-developed in toluene to remove the reagent and the bands recovered from the plates 
by extraction with n-butanol. The butanol phases were washed with water saturated with n-
butanol and the dried products subjected to GC (Sassaki et al., 2005) and GC/MS as described 
(Lee et al., 1997; Alderwick et al., 2006a). 
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Figure Legends 
 
Fig. 1.  Biosynthetic pathway leading to arabinan formation in M. tuberculosis AG. 
 
Fig. 2. Comparison of the aftC locus within the Corynebacterianeae. (A) The locus in the 
bacteria analyzed consists of aftC which in M. tuberculosis has the locus tag Rv2673 and in 
C. glutamicum NCgl1822. The genomic region displayed encompasses 7 kb, and orthologous 
genes are highlighted accordingly. Abbreviations: M. marinum, Mycobacterium marinum; M. av 
subsp. par., Mycobacterium avium subsp. paratuberculosis; C. efficiens, Corynebacterium 
efficiens; C. jeikeium, Corynebacterium jeikeium; Nocardia farcina, Nocardia farcina IFM 
10152; Rhodococcus, Rhodococcus sp. strain RHA1. (B) AftC is a hydrophobic protein predicted 
to span the membrane 10 times and the transmembrane helices are numbered accordingly. The 
lower part of the figure shows the degree of conservation of the orthologues given in A as 
analysed by the DIALIGN method (Brudno et al., 2003). Also shown is the approximate position 
of the fully conserved aspartyl (D) and glutamyl (E) residues. 
 
Fig. 3. Generation of a MSMEG2785 null mutant. (A) A map of the MSMEG2785 region in 
the parental M. smegmatis strain and its corresponding region in the MSMEG2785 mutant. res,
 resolvase site; hyg, hygromycin resistance gene from Streptomyces hygroscopicus; sacB,
sucrose counter-selectable gene from Bacillus subtilis. Digoxigenin-labelled probes were derived 
from ~1kb upstream and downstream flanking sequences that were used to construct the 
knockout plasmid, and are indicated by thick lines with square ends. SacI digested bands 
expected in a Southern blot are indicated in roman numerals with sizes in brackets. The inset 
shows the Southern blot of SacI digested genomic DNA from the two strains with expected 
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bands indicated by arrows. (B) Growth of wild type of M. smegmatis (), M. smegmatis)aftC 
(), M. smegmatis)aftC pMV261-Ms-aftC (), and M. smegmatis)aftC pMV261-Mt-aftC ()
on TSB medium. (C) Colony morphology of wild type M. smegmatis and M. smegmatisMaftC on 
TSB/agar plates. Black bar represents 1 mm. 
 
Fig. 4. Analysis of cell wall associated lipids and bound MAMEs from M. smegmatis, M. 
smegmatis)aftC, M. smegmatis)aftC pMV261-Ms-aftC and M. smegmatis)aftC pMV261-
Mt-aftC. (A) Analysis of cell wall bound MAMEs from M. smegmatis, M. smegmatis,aftC, M. 
smegmatis,aftC pMV261-Ms-aftC and M. smegmatis,aftC pMV261-Mt-aftC. The bound 
mycolic acids from an equivalent amount of freeze-dried cells (100 mg), which were initially de-
lipidated using two consecutive extractions of CHCl3:CH3OH:H2O (10/10/3; v/v/v) at 50oC for 4 
h, were released by the addition of tetra-butylammonium hydroxide at 100°C overnight, and 
methylated as described in the “Experimental Procedures”. An equivalent aliquot from each 
strain was subjected to TLC using silica gel plates (5735 silica gel 60F254, Merck), and 
developed in petroleum ether/acetone (95:5, v/v) and charred to reveal MAMEs and compared to 
known standards (Gande et al., 2004). (B) Quantitative analysis of extractable [14C]-lipids from 
M. smegmatis, M. smegmatis,aftC, M. smegmatis,aftC pMV261-Ms-aftC and M. 
smegmatis,aftC pMV261-Mt-aftC. Lipids were extracted from cells by a series of organic 
washes as described in ‘Experimental Procedures’ (Seidel et al., 2007a). An equivalent aliquot 
(50, 000 cpm) from each strain was subjected to TLC using silica gel plates (5725 silica gel 
60F254, Merck) developed in CHCl3:CH3OH:NH4OH (80:20:2, v/v/v) and quantified using 
phosphorimaging and compared to known standards (Mikusova et al., 1995) after exposure to 
Kodak X-Omat film for 24 hours. 
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Fig. 5. GC analysis of cell walls of M. smegmatis, M. smegmatis)aftC, M. smegmatis)aftC 
pMV261-Ms-aftC and M. smegmatis)aftC pMV261-Mt-aftC. Samples of purified cell walls 
were hydrolyzed with 2M TFA, reduced, per-O-acetylated and analyzed as described under 
“Experimental Procedures” (Besra et al., 1995; Alderwick et al., 2005). 
 
Fig. 6. GC/MS analysis of cell walls of M. smegmatis, M. smegmatis)aftC, M. 
smegmatis)aftC pMV261-Ms-aftC and M. smegmatis)aftC pMV261-Mt-aftC. Samples of 
per-O-methylated cell walls were hydrolyzed with 2M TFA, reduced, per-O-acetylated and 
analyzed as described under “Experimental Procedures” (Besra et al., 1995; Alderwick et al.,
2005). 
Fig. 7. Arabinofuranosyltransferas  activity utilizing an Ara2 acceptor and membranes 
prepared from M. smegmatis, M. smegmatisaftC and M. smegmatisaftC pMV261-Mt-
aftC. (A) Biosynthetic reaction scheme of products A and B formed in 
arabinofuranosyltransferase assays using the neoglycolipid Ara2 acceptor. (B)
Arabinofuranosyltransferase activity was determined using the synthetic Ara2 acceptor in a cell-
free assay with and without EMB (1 mg/ml) as previously described (Lee et al., 1997). The 
products of the assay were resuspended prior to scintillation counting (10 %) and the remaining 
subjected to TLC using silica gel plates (5735 silica gel 60F254, Merck) in 
CHCl3:CH3OH:H2O:NH4OH (65/25/3.6/0.5, v/v/v/v) with the reaction products visualized by 
autoradiography. The TLC autoradiogram is representative of several independent experiments. 
 
Fig. 8. Arabinofuranosyltransferase activity utilizing an Ara5 acceptor and membranes 
prepared from M. smegmatis, M. smegmatisaftC and M. smegmatisaftC pMV261-Mt-
aftC. (A) Arabinofuranosyltransferase activity was determined using the synthetic Ara5 acceptor 
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in a cell-free assay with and without EMB (1 mg/ml). The products reflective of three 
independent enzyme preparations and assays were resuspended prior to scintillation counting (10 
%) and the remaining subjected to TLC using silica gel plates (5735 silica gel 60F254, Merck) in 
isopropanol:acetic acid:water (8/1/1/, v/v/v) with the reaction product X visualized by 
autoradiography. The TLC autoradiogram is representative of three independent experiments. 
(B) Ara5 and Ara6 (Appelmelk et al., 2008) acceptor standards were subjected to TLC using 
silica gel plates (5735 silica gel 60F254, Merck) in isopropanol:acetic acid:water (8/1/1/, v/v/v) 
with the reaction products visualized by staining with -naphthol followed by charring. 
Fig. 9. GC characterization of in vitro synthesized product X from the 
arabinofuranosyltransferase assays utilizing the Ara5 acceptor. (A) GC analysis of the 
partially per-O-methylated, per-O-acetylated alditol acetate derivative of product X obtained 
from assays containing membranes prepared from either M. smegmatis, M. smegmatisMaftC or 
M. smegmatis,aftC pMV261-Mt-aftC (Sassaki et al., 2005). (B) Panel illustrates the structure(s) 
of product X. 
 
Fig. 10. Mycobacterial arabinan biosynthesis and the role of AftC. 
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